Beta A-C 180t
Beta A-C 180t
Regular price
$115.95 AUD
Regular price
Sale price
$115.95 AUD
Unit price
/
per
Description:
Beta A-C® Tablets have been formulated to support healthy immune system function and reduce the severity and duration of common cold symptoms. This antioxidant formulation also supports skin health and assists connective tissue formation.
Indications
- Decrease common cold duration and relieve the severity of common cold symptoms*
- Relieve the severity of symptoms of mild upper respiratory tract infections, including respiratory tract congestion*
- Reduce symptoms of common colds and flu such as sneezing, cough, sore throat, and runny nose*
- Supports wound healing, skin repair and body tissue regeneration*
- Support collagen health and formation*
- Assist connective tissue production*
- Reduce free radicals formed in the body*
- Support healthy immune system function*
- Maintains immune system to fight illness*
- Supports blood vessel health and artery health*
- Support healthy stress response in the body*
*In adults, adolescents and ageing individuals.
Ingredients:
Ascorbic acid (Vitamin C) | 589 mg |
Sodium ascorbate | 146 mg |
equiv. Ascorbic acid | 127 mg |
Calcium ascorbate dihydrate | 104 mg |
equiv. Ascorbic acid | 84 mg |
TOTAL VITAMIN C | 800 mg |
d-alpha-tocopheryl acid succinate | 41.38 mg |
equiv. Natural Vit. E | 50 IU |
Dunaliella salina extract | 7 mg |
derived from cell fresh | 13 mg |
equiv. Carotenoids calc. as betacarotene | 525 microgram |
Rutoside (Rutin) | 150 mg |
Citrus bioflavonoids extract | 50 mg |
Zinc amino acid chelate | 10 mg |
equiv. Zinc | 2 mg |
Dose:
ADULTS & ADOLESCENTS: Take 1 to 2 tablets twice daily with food.
Or as directed by your healthcare professional.
Warnings:
- Children under two years of age should not be treated for symptoms of respiratory tract infections without medical advice.
- Vitamin and mineral supplements should not replace a balanced diet
- Contains trace amounts of sulphur dioxide
- If symptoms persist, seek additional professional advice.